Dominique Lambright, BlackDoctor.org Weight-loss medications like Ozempic, Wegovy, and Mounjaro are changing the way millions ...

The White House recently announced a landmark deal with pharmaceutical companies Eli Lilly and Nordisk that will impact ...

New research suggests GLP-1 weight-loss drugs like Ozempic and Zepbound may reduce cravings for alcohol and drugs by ...

Scientists are uncovering how GLP-1 drugs like Ozempic and Wegovy act on brain regions that control hunger, nausea, pleasure-based eating, and thirst. These discoveries may help create treatments that ...

When Susan Akin first started injecting a coveted weight-loss drug early this year, the chaos in her brain quieted. The ...

Eli Lilly and Company, Novo Nordisk A/S Class B, Novo Nordisk A/S Class B, Novo Nordisk B. Read The Tokenist (Timothy Fries)'s latest article on Investing.com Canada.

Novo Nordisk announced Monday that it is significantly cutting the prices of its blockbuster GLP-1 drugs, Wegovy (for weight ...

Originally developed for diabetes, GLP-1 drugs like Ozempic are showing remarkable potential in combating addiction. Emerging ...

Until the end of March, Novo Nordisk will let people with prescriptions buy the first two doses of the drugs for $199 a month ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the ...

By moving early, Novo Nordisk has got in with its price cut ahead of Lilly, whose deal involved dual GLP-1/CIP agonist ...

Novo Nordisk NOVOb.CO said on Monday it has begun selling its popular weight-loss drug Wegovy for $349 a month to cash payers ...